FIELD: medical engineering.
SUBSTANCE: device has endolumen stent and transplant. The stent releases means promoting in vivo adhesion of stent to be transplanted to blood vessel wall or accelerates fibrous response contributing to tight adhesion of the stent to be transplanted to blood vessel wall in vivo in other cases.
EFFECT: wide range of functional applications.
36 cl
Title | Year | Author | Number |
---|---|---|---|
LOCAL VASCULAR DELIVERY OF mTOR INHIBITORS IN COMBINATION WITH PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR STIMULATORS | 2008 |
|
RU2510654C2 |
LOCAL VASCULAR DELIVERY OF PROBUCOL, ALONE OR IN COMBINATION WITH SIROLIMUS, FOR TREATMENT OF RESTENOSIS, VULNERABLE PLAQUES, AAA (ABDOMINAL AORTA ANEURISM) AND STROKE | 2008 |
|
RU2481084C2 |
COMPOSITIONS INHIBITING THE DEVELOPMENT OF BLOOD VESSELS AND METHOD FOR THEIR APPLICATIONS | 2001 |
|
RU2304433C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF THERAPEUTICALLY ACTIVE SUBSTANCES | 2009 |
|
RU2596092C2 |
DEVICE FOR LOCAL AND/OR REGIONAL DELIVERY USING LIQUID FORMULATIONS OF ACTIVE SUBSTANCES | 2009 |
|
RU2513153C2 |
STENT ASSEMBLY FOR THORACOABDOMINAL BIFURCATED ANEURYSM REPAIR | 2015 |
|
RU2671073C2 |
STAND FOR EXPANSION OF APERTURE INSIDE THE CANAL BODY | 1994 |
|
RU2180844C2 |
COMPOSITION AND METHODS FOR TREATMENT OR PROPHYLAXIS OF INFLAMMATORY DISEASES | 1997 |
|
RU2242974C2 |
METHOD FOR ENDOVASCULAR PREVENTION AND CORRECTION OF TYPE I ENDOLEAKS IN AORTIC ENDOPROSTHESIS | 2020 |
|
RU2752029C1 |
BIORESORBABLE IMPLANT OF BLOOD VESSELS BASED ON NANOFIBERS | 2023 |
|
RU2808880C1 |
Authors
Dates
2004-12-20—Published
1999-12-30—Filed